HS2ST1
Basic information
Region (hg38): 1:86914635-87109982
Links
Phenotypes
GenCC
Source:
- neurofacioskeletal syndrome with or without renal agenesis (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurofacioskeletal syndrome with or without renal agenesis | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Ophthalmologic; Neurologic; Renal | 33159882 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HS2ST1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 18 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 18 | 7 | 1 |
Variants in HS2ST1
This is a list of pathogenic ClinVar variants found in the HS2ST1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-86915043-C-T | Inborn genetic diseases | Uncertain significance (Feb 03, 2022) | ||
1-86915046-C-T | Inborn genetic diseases | Uncertain significance (Feb 22, 2023) | ||
1-86915095-TCGC-GAA | Neurofacioskeletal syndrome with or without renal agenesis | Pathogenic (Feb 18, 2021) | ||
1-86915129-CCAGAAA-C | Neurofacioskeletal syndrome with or without renal agenesis | Likely pathogenic (Dec 02, 2024) | ||
1-87072984-A-G | Inborn genetic diseases | Uncertain significance (Jul 09, 2021) | ||
1-87072997-G-A | Inborn genetic diseases | Uncertain significance (Sep 17, 2021) | ||
1-87073003-A-G | Inborn genetic diseases | Uncertain significance (Jan 29, 2024) | ||
1-87073006-C-T | Inborn genetic diseases • HS2ST1-related disorder | Likely benign (Jan 03, 2022) | ||
1-87073040-T-C | Likely benign (Jan 01, 2024) | |||
1-87073060-C-T | Neurofacioskeletal syndrome with or without renal agenesis | Uncertain significance (-) | ||
1-87073117-A-G | Inborn genetic diseases | Uncertain significance (Dec 16, 2022) | ||
1-87073135-C-T | Inborn genetic diseases | Uncertain significance (Feb 10, 2022) | ||
1-87073150-CA-C | NEUROFACIOSKELETAL SYNDROME WITHOUT RENAL AGENESIS | Pathogenic (Feb 18, 2021) | ||
1-87084175-A-G | Neurofacioskeletal syndrome with or without renal agenesis | Benign (Apr 11, 2023) | ||
1-87084186-C-T | Neurofacioskeletal syndrome with or without renal agenesis | Benign (Sep 01, 2024) | ||
1-87084198-G-A | Inborn genetic diseases | Uncertain significance (Dec 28, 2022) | ||
1-87084206-A-G | Inborn genetic diseases | Uncertain significance (Oct 09, 2024) | ||
1-87084236-C-G | Inborn genetic diseases | Uncertain significance (Oct 10, 2023) | ||
1-87084239-G-A | Inborn genetic diseases | Uncertain significance (Jan 08, 2024) | ||
1-87084257-G-A | Inborn genetic diseases | Likely benign (Aug 02, 2021) | ||
1-87092559-A-G | Inborn genetic diseases | Uncertain significance (Aug 13, 2021) | ||
1-87092574-G-T | Neurofacioskeletal syndrome with or without renal agenesis | Pathogenic (Feb 18, 2021) | ||
1-87092608-T-C | NEUROFACIOSKELETAL SYNDROME WITHOUT RENAL AGENESIS | Pathogenic (Feb 18, 2021) | ||
1-87092648-A-C | Neurofacioskeletal syndrome with or without renal agenesis | Pathogenic (Feb 18, 2021) | ||
1-87097906-G-A | Likely benign (Feb 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HS2ST1 | protein_coding | protein_coding | ENST00000370550 | 7 | 222004 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.545 | 0.455 | 125733 | 0 | 8 | 125741 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.51 | 135 | 194 | 0.695 | 0.0000100 | 2349 |
Missense in Polyphen | 28 | 62.293 | 0.44949 | 788 | ||
Synonymous | 0.946 | 61 | 71.2 | 0.857 | 0.00000367 | 639 |
Loss of Function | 3.27 | 4 | 19.7 | 0.203 | 0.00000116 | 226 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.000102 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000358 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the transfer of sulfate to the C2-position of selected hexuronic acid residues within the maturing heparan sulfate (HS). 2-O-sulfation within HS, particularly of iduronate residues, is essential for HS to participate in a variety of high- affinity ligand-binding interactions and signaling processes. Mediates 2-O-sulfation of both L-iduronyl and D-glucuronyl residues (By similarity). {ECO:0000250}.;
- Pathway
- Glycosaminoglycan biosynthesis - heparan sulfate / heparin - Homo sapiens (human);Metapathway biotransformation Phase I and II;Metabolism of carbohydrates;HS-GAG biosynthesis;Heparan sulfate/heparin (HS-GAG) metabolism;Glycosaminoglycan metabolism;heparan sulfate biosynthesis (late stages);heparan sulfate biosynthesis;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.142
Intolerance Scores
- loftool
- 0.251
- rvis_EVS
- -0.01
- rvis_percentile_EVS
- 53.51
Haploinsufficiency Scores
- pHI
- 0.854
- hipred
- N
- hipred_score
- 0.302
- ghis
- 0.622
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.517
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hs2st1
- Phenotype
- pigmentation phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; craniofacial phenotype;
Zebrafish Information Network
- Gene name
- hs2st1a
- Affected structure
- blastoderm cell
- Phenotype tag
- abnormal
- Phenotype quality
- increased size
Gene ontology
- Biological process
- glycosaminoglycan biosynthetic process;heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process;heparan sulfate proteoglycan biosynthetic process, enzymatic modification
- Cellular component
- Golgi membrane;membrane;integral component of membrane
- Molecular function
- heparan sulfate 2-O-sulfotransferase activity;sulfotransferase activity